stocks logo

HQY Earnings

Healthequity Inc
$
89.840
-3.14(-3.377%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

Earning Analysis

Welcome to our in-depth analysis of Healthequity Inc(HQY) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Healthequity Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.

Earnings Forecast

Revenue
EPS
Currency: USD
Actual
Estimate

Surprise Analysis

Name
EPS
Revenue
Price Reaction
Fiscal QuarterEarning DateTimeEstimateActualSurprise%EstimateActualSurprise%1D5D
FY2026Q12025-06-03After Hours0.810.97+19.75322.07M330.84M+2.73+8.96+7.13
FY2025Q42025-03-18After Hours0.720.69-4.17305.82M311.82M+1.96-17.07-11.29
FY2025Q32024-12-09After Hours0.720.78+8.33290.00M300.43M+3.60-5.55-7.75
FY2025Q22024-09-03After Hours0.700.86+22.86285.12M299.93M+5.19+5.13-5.01
FY2025Q12024-06-03-0.470.55+17.02277.93M287.60M+3.48-0.56+4.37
FY2024Q42024-03-19-0.420.50+19.05258.99M262.39M+1.31+0.69-4.32
FY2024Q32023-12-05-0.320.40+25.00243.61M249.22M+2.30-0.06+2.61
FY2024Q22023-09-05-0.280.34+21.43240.00M243.55M+1.48+0.63+5.45
-2023-06-05-0.230.32+39.13----0.71+9.40
-2023-03-21-0.200.26+30.00---+2.81+1.80

HQY Earnings Analysis

Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Healthequity Inc reported performance for FY2026Q1, announced on 2025-06-03. The company achieved an EPS of 0.97, compared to analyst estimates of 0.81 by 19.75% . Revenue for the quarter reached 330.84M compared to expectations of 322.07M by 2.73% .
The stock price reacted with a 8.96% one-day change and a 7.13% five-day change following the earnings release. These movements reflect market reaction in Healthequity Inc growth trajectory and strategic initiatives.

HQY Earnings Forecast

Looking ahead, Healthequity Inc(HQY) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2026/Q2 project quarter revenue of 320.69M and an EPS of 0.92.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2026 have been Revise Upward by 0.1%, while EPS estimates have been Revise Upward by 2.93%. For the upcoming Q2 2026, revenue estimates have been adjusted Revise Downward by -0.09% . These revisions correlate with a -7.37% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Healthequity Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.

Estimate Revision

The chart shows the correlation between HQY's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2026
Revise Upward
up Image
+0.1%
In Past 3 Month
EPS Estimates for FY2026
Revise Upward
up Image
+2.93%
In Past 3 Month
Revenue Estimates for Q2 2026
Revise Downward
down Image
-0.09%
In Past 3 Month
Stock Price
Go Down
down Image
-7.37%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2026
Currency: USD
--
Revenue Estimate-Annual FY 2026:1.30B
--
EPS Estimate-Annual FY 2026:3.73
Stock Price89.84

HQY Revenue and EPS Performance: A Historical Perspective

Healthequity Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2026Q1 (2025-06-03,After Hours):
EPS: 0.97 (Actual) vs.0.81 (Estimate) (19.75%)
Revenue: 330.84M (Actual) vs. 322.07M (Estimate) (2.73%)
Price Reaction: 8.96%(1-Day), 7.13%(5-Day)
FY2025Q4 (2025-03-18,After Hours):
EPS: 0.69 (Actual) vs.0.72 (Estimate) (-4.17%)
Revenue: 311.82M (Actual) vs. 305.82M (Estimate) (1.96%)
Price Reaction: -17.07%(1-Day), -11.29%(5-Day)
FY2025Q3 (2024-12-09,After Hours):
EPS: 0.78 (Actual) vs.0.72 (Estimate) (8.33%)
Revenue: 300.43M (Actual) vs. 290.00M (Estimate) (3.60%)
Price Reaction: -5.55%(1-Day), -7.75%(5-Day)
Earnings Reaction
The chart below shows how HQY performed 10 days before and after its earnings report, based on data from the past quarters. Typically, HQY sees a +0.28% change in stock price 10 days leading up to the earnings, and a -2.19% change 10 days following the report. On the earnings day itself, the stock moves by +0.43%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in APR/2025, the stock changed 8.96% on the day following the earnings release and then changed by -3.61% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.

Transcript Summary

Healthequity Inc (HQY) Q1 2026 Earnings Call Summary
Positive
2025-06-03
The earnings call summary shows strong financial performance with significant revenue growth, increased gross profit margin, and a robust share repurchase plan. The Q&A section reveals management's optimism about the pipeline and successful fraud prevention, though some responses were vague. The raised guidance and record HSA assets further enhance the positive outlook. Given these factors, a positive stock price movement is likely, despite potential macroeconomic concerns.
Healthequity Inc (HQY) Q4 2025 Earnings Call Summary
Positive
2025-03-18
The earnings call reveals solid financial performance with record custodial revenue growth and a significant increase in total revenue. The optimistic guidance for FY 2026, alongside a strong share repurchase plan, indicates confidence in future growth. Despite some challenges, such as increased service costs and competitive pressures, the company's strategic initiatives and legislative advocacy suggest a positive outlook. The Q&A section highlights management's commitment to addressing concerns and leveraging opportunities, further supporting a positive sentiment. Overall, these factors suggest a likely positive stock price movement in the near term.
Healthequity Inc (HQY) Q4 2025 Earnings Call Summary
Positive
2025-03-18
The earnings call summary shows strong financial performance with record revenues, a significant share repurchase plan, and optimistic growth prospects. The Q&A highlights some concerns about fraud-related costs, but these are expected to normalize. The guidance for FY 2025 and FY 2026 is optimistic, with revenue and adjusted EBITDA growth. Despite some uncertainties, the overall sentiment is positive, suggesting a potential stock price increase of 2% to 8% over the next two weeks.
HealthEquity, Inc. (HQY) Q3 2025 Earnings Call Summary
Positive
2024-12-10
The earnings call reveals strong financial performance with significant revenue and profit growth, a robust share repurchase program, and optimistic guidance. The Q&A section highlights positive trends in HSA growth and market potential, although some management responses were vague. Despite high debt levels, the company's strategic initiatives and capital allocation plans suggest a positive outlook. These factors collectively indicate a likely positive stock price movement in the short term.
HealthEquity, Inc. (HQY) Q2 2025 Earnings Call Summary
Positive
2024-09-04
The earnings call summary shows strong financial performance with a 23% revenue increase and improved profit margins. The acquisition of BenefitWallet and a $300 million share repurchase are positive catalysts. The Q&A reveals some uncertainty around future financial impacts, but overall, the strong growth in new accounts and investments, along with optimistic guidance, suggest a positive stock movement. The announcement of share repurchase should further support this sentiment.

FAQ

arrow icon

What were the key highlights of HQY’s latest earnings report for FY2026Q1?

HQY reported its FY2026Q1 earnings on 2025-06-03, showcasing a revenue of 330.84M against an estimate of 322.07M, resulting in a 2.73% surprise. The EPS was 0.97, surpassing the expected 0.81 by 19.75% . The stock experienced a 8.96% price change on the earnings day and a 7.13% change over the next five days, reflecting market reactions to the results.
arrow icon

How did HQY’s stock price react after the FY2026Q1 earnings release?

arrow icon

What are the revenue and EPS estimates for HQY for 2026/Q2?

arrow icon

How does HQY’s stock price correlate with earnings forecast revisions?

arrow icon

What should investors expect from HQY’s next earnings report?

arrow icon

What is the sentiment in Healthequity Inc (HQY) Q1 2026 Earnings Call Summary?